PeptideStack
5.2kquestions
20kanswers
220users

Is ferritin worth drawing at baseline before starting liraglutide?

Asked 16 Aug 2025Modified 8 months agoViewed 22k times
23

Setup, so nobody has to ask: ferritin · liraglutide.

The failure mode I am trying to avoid is making this decision emotionally.

I have twelve months in view and I would like the plan to survive that long.

How would you structure this, and what thresholds would you set in advance?

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questions
a1c
a1c

Glycated haemoglobin as a ninety-day glycaemic average: what a change of half a point means, why it lags, and the conditions under which it…

122 questions
liraglutide
liraglutide

A once-daily GLP-1 receptor agonist and the compound that established the class. Still relevant for its shorter half-life, its paediatric and…

235 questions
shareeditfollowflag
P9
askedplate_count_9k78k24816 Aug 2025
3Is there a repeat draw, or is this a single value? One value is a point, not a trend. – zeynep_arslan 1 days ago
2Which equation produced the eGFR? They disagree by enough to matter at the margins. – Dr_Nadia_Farsi 8 months ago
add a comment

5 Answers

Accepted answer first, then by votes
120

Accepted answer

Start with a baseline. A result taken before anything started converts most later ambiguity into a simple comparison, and it cannot be obtained retrospectively.

Repeat before you react. A single abnormal value has a substantial probability of being within the combined biological and analytical variation of a normal one.

Keep the reports rather than the numbers. Units, reference intervals and methods all vary, and a bare number two years later is not comparable to anything.

Pre-analytical factors — posture, tourniquet time, fasting, sample handling — are the largest source of error in routine biochemistry, well ahead of the analysis itself.

Nothing here is medical advice. If something is out of range and you do not know why, that is a consultation rather than a research project.

One out-of-range value on a twenty-analyte panel is expected. Two on a repeat is a finding.

shareimprove this answerflag
PC
answered · acceptedpk_curve30k283 Dec 2025
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
47

The relevant statistical point is that a ninety-five per cent reference interval means one analyte in twenty will read out of range in a healthy person by construction.

Same laboratory, same method, same time of day, same fasting state. Between-laboratory differences on several common analytes are larger than the changes people are trying to detect.

To be exact about it, a twenty-analyte panel run on a healthy person will produce, on average, one out-of-range result purely from how reference intervals are constructed. That is arithmetic rather than pathology.

Baseline first, then a repeat under identical conditions. Everything else is secondary.

shareimprove this answerflag
VV
answeredvoid_volume9.5k1516 Aug 2025
28

Before reacting to any single value, check whether it is outside the interval by an amount larger than the assay's own variation.

Timing matters per analyte: cortisol and testosterone are diurnal, triglycerides are postprandial, and creatinine responds to hydration and to recent training. Fixing the conditions removes most of the noise.

It helps to be literal here: a sensible core for this population is a full blood count, renal function with electrolytes, liver enzymes with bilirubin, a fasting lipid panel with apolipoprotein B, HbA1c and thyroid-stimulating hormone.

Keep the full report, not the number. You will need the units and the interval later.

shareimprove this answerflag
BU
answeredbufferline4230k13822 Nov 2025
Same laboratory every time is advice I ignored for a year, and the series was useless because of it. – Dr_Bram_Verhoeven 5 months ago
add a comment
23

The short version: a small, well-chosen panel with a baseline beats a large one without.

Haemolysis in the sample raises potassium and several enzymes spuriously. If a result is bizarre, ask whether the sample was flagged before building a theory on it.

Ordering tests you will not act on generates anxiety and incidental findings, both of which have costs.

Same laboratory, same time, same fasting state, or the comparison is not a comparison.

shareimprove this answerflag
WC
answeredwren_calloway23k3819 Sept 2025
2The one-in-twenty out-of-range arithmetic should be printed at the top of every panel report. – Dr_Yusuf_Adeyemi 2 months ago
3Worth flagging that a mild enzyme elevation with a normal bilirubin is a different object from a rising one. – nkem_obiora 4 months ago
add a comment
-2

The honest position is that most people order too many analytes and too few time points, when the reverse would be more informative.

Delta checks — comparing against your own previous value — are far more sensitive than comparing against a population interval, which is the argument for keeping a series rather than a snapshot.

Reference intervals are conventionally the central ninety-five per cent of a reference population, which is the direct cause of the one-in-twenty out-of-range rate on a healthy panel.

Decide the action for each result before you order the test.

shareimprove this answerflag
LF
answeredleah_ferrers12k1611 Nov 2025
Thank you — this is the answer I was looking for. – Dr_Marek_Zielinski 4 months ago
8Thank you — separating "out of range" from "abnormal" is the distinction I needed. – Dr_Ingrid_Baumgartner 3 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.